Anavex Life Sciences Corp (AVXL)

[Swan5995]

Sale of 2-73 possible. Silence likely NDA (non-disclosure agreement). However, many other permutations are possible with a 'deal'.

If there isn't a PR in the morning discussing a release of 2-73 data I wouldn't expect any new info until some time after the shareholder's meeting. It will take some time to finalize an agreement (assuming there is one in the works) before the details are released.

I assume the agreement involves AD and possibly/likely other indications since an NDA for just MS would be more specific and not effect the release of P2a data.

Total speculation on my part but I don't expect to see any new information released on 2-73 this week. This will drive down the share price and will provide a buying opportunity. There will be speculation that new information will be released at the annual shareholder's meeting...again, nothing new released, still tight lipped. Share price hit again. Then in the days/weeks/up to a couple of months following the meeting some sort of deal will be announced.

Partner likely Biogen but could be others. Missling didn't mention them verbally during Vienna presentation when he recognized all other contributors to preclinical funding of the various indications. They appeared on the slide but no verbal acknowledgment. Lips are tight when deals are being made.

Then again, I could be proven wrong in a few hours with a morning PR.